FDA has approved the first mRNA-based seasonal influenza vaccine for adults 50 years and older. The vaccine is indicated for the prevention of influenza disease

FDA has approved the first mRNA-based seasonal influenza vaccine for adults 50 years and older. The vaccine is indicated for the prevention of influenza disease caused by influenza A subtypes and influenza B strains represented in the vaccine. Approval includes: ➡️Traditional Approval for adults 50…